The animal model of Alzheimer’s is broken! Or is it? The latest failure was Biogen’s much hyped anti-amyloid drug, aducanumab — a drug designed to slow the worsening of Alzheimer’s by targeting the brain-destroying protein fragment known as beta-amyloid. This prototype held much promise as the ‘last man standing’ after a long string of similar...Read More